ROFLUMILAST TABLETS
Zydus Lifesciences gets USFDA nod for 2 generic drugsThe tentative approval granted by the US Food and Drug Administration (USFDA) to the company's arm Zydus Worldwide DMCC to market Valbenazi...
Zydus Pharmaceuticals (USA) Inc gets final US FDA approval to market Roflumilast tabletsRoflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chro...
Strides Shasun gets tentative nod from USFDA for Roflumilast tabletsThe product will manufacture the product in Bengaluru, has received approval in 15 months under the USFDA new product clear regime.
- Load More